THYNK CAPITAL
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.
THYNK CAPITAL
Industry:
Biotechnology Health Care
Founded:
2011-03-04
Status:
Active
Contact:
+27 217887771
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon WordPress SSL By Default Font Awesome Organization Schema Sitelinks Search Box
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-08-20 | IMX | Thynk Capital investment in Seed Round - IMX | N/A |
| 2021-03-05 | iviva medical | Thynk Capital investment in Seed Round - iviva medical | N/A |
| 2019-05-30 | Viscient Biosciences | Thynk Capital investment in Seed Round - Viscient Biosciences | N/A |
| 2019-05-07 | Repair Biotechnologies | Thynk Capital investment in Seed Round - Repair Biotechnologies | 2.15 M USD |
| 2019-04-05 | X-Vax Technology | Thynk Capital investment in Series A - X-Vax Technology | N/A |
| 2019-04-01 | Repair Biotechnologies | Thynk Capital investment in Convertible Note - Repair Biotechnologies | N/A |
| 2018-11-06 | Elicio Therapeutics | Thynk Capital investment in Venture Round - Elicio Therapeutics | N/A |
| 2018-06-25 | KitoTech Medical | Thynk Capital investment in Convertible Note - KitoTech Medical | N/A |
| 2018-03-22 | Marina Biotech | Thynk Capital investment in Post-IPO Equity - Marina Biotech | N/A |
| 2018-02-20 | Elevian | Thynk Capital investment in Convertible Note - Elevian | 2.9 M USD |
More informations about "Thynk Capital"
Thynk Capital - A Privately-Owned Investment Group led by Jim …
Jim Plante is a leader in technology and healthcare investment, with over 20 years of experience and 100X return potential. He is the founder of Thynk Capital, Klotho Therapeutics, Pathway …See details»
Thynk Capital - Crunchbase Investor Profile & Investments
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending …See details»
Thynk Capital - Investments, Portfolio & Company Exits
Aug 20, 2021 Thynk Capital 's most notable exits include Elicio Therapeutics, Fisker, and Marina Biotech. Which industries has this organization had the most exits in? Show . Elicio …See details»
Thynk Capital Company Profile | Management and Employees List
Thynk Capital Profile and History Thynk Capital, founded by Jim Plante, is focused on early-stage Therapeutics, Healthcare and Technology companies. We tend to invest early in capital …See details»
Thynk Capital, LLC. | LinkedIn
Thynk Capital, LLC. | 870 followers on LinkedIn. Investing in early stage companies focused on extending human HealthSpan and Diseases of Aging. | Capital efficient, early stage …See details»
Thynk Capital, LLC. Overview | SignalHire Company Profile
Thynk Capital, LLC. is a private company. The company currently specializes in the Investment Management area Thynk Capital, LLC. is a private company. ... Organization Website: …See details»
Thynk Capital - Org Chart, Teams, Culture & Jobs - The Org
View Thynk Capital's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Thynk Capital Holdings - Crunchbase Company Profile & Funding
Organization. Thynk Capital Holdings . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Thynk Capital Holdings specializes in debt and equity capital markets, …See details»
Thynk Capital, LLC. | Company | RadialReport
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending …See details»
Theragene Pharmaceuticals - Thynk Capital
Theragene Pharmaceuticals is creating life-changing cancer and cardiology treatments through the development of our novel immunotherapy and Adeno-Associated Virus (AAV) gene …See details»
Thynk Capital | Investor | Mindmaps
Thynk Capital Investor Thynk Capital, founded by Jim Plante, is focused on early-stage Therapeutics, Healthcare and Technology companies. The investment strategy has a strong …See details»
Thynk Capital | Debt Capital & Equity Solutions South Africa
Thynk Capital provides debt capital and equity solutions. Our mission is to accelerate growth of the businesses that we invest in, while creating long-term value for our investors. Our team …See details»
Thynk Capital, LLC. — 18 Investments, Portfolio, Team members — …
Thynk Capital, LLC. appeared to be the VC, which was created in 2011. The main office of represented VC is situated in the Las Vegas. The venture was found in North America in …See details»
Thynk Capital, LLC. - BioCentury Company Profiles - BCIQ
Thynk Capital, LLC. - BioCentury Company Profiles for the biopharma industrySee details»
In the News - Thynk Capital Portfolio Announcements
Oct 3, 2019 Thynk Capital provides capital to shape the future with innovations in technology and life sciences - Read the latest headlines from our portfolio companiesSee details»
Thynk Capital - Contacts, Employees, Board Members
Thynk Capital . Connect to CRM . Save . Summary. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Thynk Capital has 1 current …See details»
Thynk Capital founder hand-picked for Forbes council
Jun 21, 2022 “I’m thrilled to join this prestigious global organization,” said Travis. “At Thynk Capital Holdings, we know that great things in business are achieved by collaboration and …See details»
Thynk Health Company Profile 2024: Valuation, Funding
Thynk Health General Information Description. Developer of a cloud-based healthcare data system designed to identify lung cancer patients and incidental findings. The company's …See details»
Fisker Inc. - Thynk Capital
Fisker Inc. - Thynk Capital ... NYSE:FSRSee details»